Bio-Rad Laboratories BIO Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $2.58B+0.7% | $2.57B-3.9% | $2.67B-4.7% | $2.8B-4.1% | ||
| $1.24B+4.7% | $1.19B-4.5% | $1.24B+0.8% | $1.23B-3.9% | ||
| $1.34B-2.8% | $1.38B-3.4% | $1.43B-9.0% | $1.57B-4.4% | ||
| 51.9%-1.9pp | 53.7%+0.3pp | 53.4%-2.5pp | 55.9%-0.2pp | ||
| $275.6M-6.9% | $295.9M+19.6% | $247.4M-3.7% | $256.9M-1.4% | ||
| $844.3M+3.7% | $814M-3.3% | $841.7M+1.7% | $827.8M-5.6% | ||
| —— | $268.9M-20.4% | $337.8M-30.0% | $482.6M-3.5% | ||
| $49M+0.2% | $48.9M-1.0% | $49.4M+29.7% | $38.1M+2,356% | ||
| $90.3M0.0% | $90.3M-15.2% | $106.5M+138% | $44.7M+66.9% | ||
| $995.5M+142% | -$2.34B— | —— | —— | ||
| $235.6M+147% | -$498.3M— | —— | —— | ||
| $27.65+143% | -$65.04-203% | -$21.49+82.3% | -$121.25-186% | ||
| $1.11B+312% | $268.9M-20.4% | $337.8M-30.0% | $482.6M-3.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Bio-Rad Laboratories's revenue?
- Bio-Rad Laboratories (BIO) generated $2.6B in revenue over the trailing twelve months, up 1.9% year over year.
- Is Bio-Rad Laboratories profitable?
- Bio-Rad Laboratories reported $168.8M in net income over the trailing twelve months, a 6.5% net margin.
- What are Bio-Rad Laboratories's profit margins?
- Gross margin is 51.9% and operating margin is 8.8%, with a 6.5% net margin.
- What is Bio-Rad Laboratories's earnings per share?
- Bio-Rad Laboratories's diluted EPS over the trailing twelve months is $5.81.
- Where does Bio-Rad Laboratories's income statement data come from?
- Every line is extracted from Bio-Rad Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
